GROVE, INC. (GRVI): Price and Financial Metrics Recent IPO


GROVE, INC. (GRVI): $5.29

-0.04 (-0.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GRVI Stock Price Chart Interactive Chart >

Price chart for GRVI

GRVI Price/Volume Stats

Current price $5.29 52-week high $9.37
Prev. close $5.33 52-week low $3.86
Day low $5.00 Volume 349,339
Day high $5.40 Avg. volume 2,024,451
50-day MA $5.23 Dividend yield N/A
200-day MA $0.00 Market Cap 75.16M

GROVE, INC. (GRVI) Company Bio


Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. Grove, Inc. was incorporated in 2018 and is headquartered in Henderson, Nevada.


GRVI Latest News Stream


Event/Time News Detail
Loading, please wait...

GRVI Latest Social Stream


Loading social stream, please wait...

View Full GRVI Social Stream

Latest GRVI News From Around the Web

Below are the latest news stories about Grove Inc that investors may wish to consider to help them evaluate GRVI as an investment opportunity.

Grove, Inc. Announces Unaudited Fiscal Year 2021 Results of Operations

Offers Revenue Guidance for 2022 of $48-55 Million● $24.1 million in revenue for fiscal year 2021 ● $2.0 million in net income for fiscal year 2021 ● Year-end June 30, 2022 revenue guidance of $48-$55 Million HENDERSON, NV, Sept. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"), a global innovator in hemp, health, and wellness, today announced unaudited financial results for its fiscal year ended June 30, 2021 were in line with preliminary res

Yahoo | September 16, 2021

Alfi Brings Grove's Cannabis Ads to the Backseat of Your Uber Ride

Source: Alfi Even as a myriad of wellness benefits from CBD products pile up, the cannabis industry faces stiff headwinds when it comes to advertising its products. The two largest digital advertising platforms Google Inc. (NASDAQ: GOOGL) and Facebook (NASDAQ: FB) do not permit ads promoting CBD or hemp-based products. Therefore, companies have had to get creative when it comes to marketing and advertising, with many relying on traditional advertising methods such as billboards and radio spots.

Yahoo | September 16, 2021

Grove Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

HENDERSON, NV, Sept. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Grove Inc. (the “Company” or “Grove”) (NASDAQ: GRVI), Nevada company engaging in the research, manufacturing, distribution, and marketing of CBD and hemp wellness-based products, today announced that Allan Marshall, Grove’s Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually on September 13-15, 2021. The prerecorded presentation will become available on Mon

Yahoo | September 10, 2021

Growing CBD Industry Still in Murky Regulatory Environment

Image by Julia Teichmann from Pixabay When the 2018 Farm Bill legalized the production of hemp as an agricultural commodity, it opened up a new world for companies that extract cannabinoids from the plants. Entrepreneurs across the United States have since built businesses that focus on manufacturing products that are infused with the extracts. These companies are infusing everything from gummy edibles and vaporizers to topical creams and lotions and even beauty products with cannabidiol (CBD),

Yahoo | September 7, 2021

Research Finds Multiple Benefits of Rare Cannabinoids

Photo by Andre Taissin on Unsplash As the medicinal benefits of cannabis continue to be explored, researchers are beginning to understand that the cannabinoids found in the plant go way beyond those that most people are familiar with: tetrahydrocannabinol (THC), the main psychoactive cannabinoid in the marijuana plant, and cannabidiol (CBD), a nonpsychoactive compound that is believed to relieve pain, reduce anxiety and induce sleep. But with more than 200 known cannabinoids and an increasing am

Yahoo | August 26, 2021

Read More 'GRVI' Stories Here

GRVI Price Returns

1-mo -22.21%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6408 seconds.